Stephen Colvill is an Assistant Research Director at the Duke-Margolis Institute for Health Policy, where he leads the Duke-Margolis ReVAMP Drug Supply Chain Consortium and policy work on other supply chain and biomedical innovation topics.
Stephen is also a board member for the End Drug Shortages Alliance and a volunteer advisor for Angels for Change, and he frequently speaks at national forums on pharmaceutical supply chains, drug shortages, pharmaceutical regulation, and biomedical innovation.
Stephen previously served in the White House Domestic Policy Council as Senior Policy Advisor for Medical Supply Chains. He also co-founded RISCS, a nonprofit drug supply chain rating and certification organization with a mission to prevent drug shortages, and held various roles at Pfizer and Hospira in business analytics, supply chain, manufacturing, finance, marketing, and commercial portfolio management.
